🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Entain downgraded to sell at Goldman Sachs due to disappointing online growth, BetMGM JV losing US market share

Published 11/27/2023, 08:15 AM
Updated 11/27/2023, 08:17 AM
© Reuters Entain downgraded to sell at Goldman Sachs due to disappointing online growth, BetMGM JV losing US market share
ENT
-

London-listed sports betting, gaming and interactive entertainment company Entain (LN) (GMVHF) was double downgraded to Sell from Buy at Goldman Sachs, with the price target slashed to 820p from 1,450p per share.

Analysts told investors that they are downgrading the stock based on the firm's view of the fundamentals and because they believe the company's free cash flow yield merits caution.

The investment bank noted they have been wrong on Entain previously due to the company's disappointing online growth, owing to a mix of regulatory headwinds, competition, market dynamics, and unfavourable sports results "contributing to material downward consensus EPS revisions." In addition, they pointed to the joint venture with BetMGM losing market share in the US and the larger-than-expected £585 million HMRC settlement.

"Our prior Buy thesis looked for Online growth to inflect from 3Q23, and the US JV to become meaningfully profitable in 2024 and potentially return capital to the parents (acting as a catalyst for the JV's value to be recognised within Entain), together driving a re-rating from a seemingly attractive EV/EBITDA multiple on our prior estimates," explained the analysts.

"We now believe the inflection of fundamentals will take longer to come through, leading us to cut our estimates (by c.30% at EPS for FY24/25E). On our new estimates, we view Entain's valuation (2.2% 2024E GS FCF yield (or 4.9% excluding the year's HMRC settlement payment) vs. our coverage median at 6%) as relatively demanding on fundamentals, when set against our broader coverage," they added. "As such, absent external catalysts (e.g. an approach), we would expect the shares to continue to underperform within our coverage on a 12-month view."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.